Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLB vs MRNA✓SelectedUSD · MRNAXLB vs MRNA performance historyLatest closeAs of-0.75%11/18
Stock and ETF performance explorer

XLB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+128.4%
MRNA return
+794.5%
Excess return
-666.1%
Maximum drawdown
-37.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.7%-4.8%+4.1%-0.6%
7D-4.8%-20.9%+16.0%-4.1%
30D-1.0%-13.3%+12.3%-0.6%
3M-2.1%+212.6%-214.7%-8.2%
6M+1.3%+309.0%-307.7%-6.6%
YTD+12.7%+567.3%-554.6%+1.1%
1Y+20.1%+689.7%-669.5%+6.8%
3Y+33.2%+157.4%-124.3%+21.9%
5Y+26.0%-21.7%+47.7%+17.4%
All+128.4%+794.5%-666.1%+106.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling